Allspring Global Investments’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-517
Closed -$1.47K 2395
2024
Q1
$1.47K Buy
+517
New +$1.59K ﹤0.01% 2219
2023
Q4
Sell
-1,851
Closed -$4.79K 2280
2023
Q3
$4.79K Sell
1,851
-13,110
-88% -$46K ﹤0.01% 2677
2023
Q2
$58.9K Sell
14,961
-3,803
-20% -$12.1K ﹤0.01% 2248
2023
Q1
$63.4K Buy
18,764
+17,629
+1,553% +$71.9K ﹤0.01% 2206
2022
Q4
$4.06K Sell
1,135
-25
-2% -$107 ﹤0.01% 2796
2022
Q3
$4K Buy
+1,160
New +$5.96K ﹤0.01% 2790

Other funds holding SRTA

Allspring Global Investments's SRTA Position: Q2 2024 in Review

Allspring Global Investments sold out of Strata Critical Medical Inc (SRTA) in Q2 2024, closing a stake of 517 shares — an estimated $1.47K sold.

Allspring Global Investments first reported a position in SRTA in Q3 2022 and held it in 6 quarters. The position peaked at $63.4K in Q1 2023. 117 funds tracked by Wall St. Rank hold SRTA as of Q2 2024.

  • Allspring Global Investments reported no remaining Strata Critical Medical Inc position as of Q2 2024 after selling out during the quarter.
  • Allspring Global Investments sold 517 Strata Critical Medical Inc shares in Q2 2024, an estimated $1.47K.
  • Allspring Global Investments first reported a position in Strata Critical Medical Inc in Q3 2022 and held it in 6 quarters.
  • Allspring Global Investments's Strata Critical Medical Inc position peaked at $63.4K in Q1 2023.
  • 117 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2024.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.